Tak Paul Peter
Chief Executive Officer at CADL
- Sold, on record
- $4.2M
- Dollars the filings state
- Form 4 sales
- 7
- Latest Sep 11, 2026
- Form 144 notices
- 7
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- CADLCandel Therapeutics, Inc.Chief Executive Officer
Sales by reason
Form 4 sales per month, every sale on record.
Timeline
- 1 Form 144 notice CADLNoticeJan 8, 2025 2025
Filed to sell 20,811 shares ($174k)
Tak Paul Peter, Officer, Director
No 10b5-1 plan0.9x usual sizeFiling
- 2 Form 4 sale CADLNo planJan 8, 2025 same day
Sold 21,172 shares at $8.22 ($174k)
Tak Paul Peter, Chief Executive Officer
No 10b5-1 planSold 7.2% of holdings ($2.4M position)273,616 shares left0.9x usual sizeFollows a Form 144Filing
- 3 Form 144 notice CADLNoticeJan 15, 2025 +7 days
Filed to sell 19,970 shares ($157k)
Tak Paul Peter, Officer, Director
No 10b5-1 plan0.9x usual sizeFiling
- 4 Form 4 sale CADLNo planJan 15, 2025 same day
Sold 21,704 shares at $7.23 ($157k)
Tak Paul Peter, Chief Executive Officer
No 10b5-1 planSold 7.9% of holdings ($2M position)251,912 shares left1x usual sizeFollows a Form 144Filing
- 5 Form 144 notice CADLNoticeMar 18, 2025 +62 days
Filed to sell 74,106 shares ($654k)
Tak Paul Peter, Director, Officer
10b5-1 plan3.4x usual sizeFiling
- 6 Form 4 sale CADLRoutineMar 19, 2025 +1 day
Sold 26,172 shares at $8.77 ($230k)
Tak Paul Peter, Chief Executive Officer
10b5-1 planSold 10.4% of holdings ($2.2M position)225,740 shares left1.2x usual sizeFollows a Form 144Filing
- 7 Form 144 notice CADLNoticeSep 10, 2026 +540 days
Filed to sell 280,245 shares ($3.4M)
Tak Paul Peter, Director, Officer
10b5-1 plan11.7x usual sizeFiling
- 8 Form 4 sale CADLUnusualSep 11, 2026 +1 day
Sold 280,245 shares at $11.28 ($3.2M)
Tak Paul Peter, Chief Executive Officer
10b5-1 planSold 71.2% of holdings ($4.4M position)113,321 shares left11.7x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (14)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Sep 11, 2026 | Sep 11, 2026 | CADL | Chief Executive Officer | Form 4 sale | 280,245 | $3.2M | 71.2% | Unusual | SEC |
| Sep 10, 2026 | Sep 10, 2026 | CADL | Director, Officer | Form 144 notice | 280,245 | $3.4M | Notice | SEC | |
| Mar 19, 2025 | Mar 20, 2025 | CADL | Chief Executive Officer | Form 4 sale | 26,172 | $230k | 10.4% | Routine | SEC |
| Mar 18, 2025 | Mar 18, 2025 | CADL | Director, Officer | Form 144 notice | 74,106 | $654k | Notice | SEC | |
| Jan 15, 2025 | Jan 17, 2025 | CADL | Chief Executive Officer | Form 4 sale | 21,704 | $157k | 7.9% | No plan | SEC |
| Jan 15, 2025 | Jan 15, 2025 | CADL | Officer, Director | Form 144 notice | 19,970 | $157k | Notice | SEC | |
| Jan 8, 2025 | Jan 10, 2025 | CADL | Chief Executive Officer | Form 4 sale | 21,172 | $174k | 7.2% | No plan | SEC |
| Jan 8, 2025 | Jan 8, 2025 | CADL | Officer, Director | Form 144 notice | 20,811 | $174k | Notice | SEC | |
| Nov 29, 2024 | Dec 3, 2024 | CADL | Chief Executive Officer | Form 4 sale | 48,847 | $223k | 14.2% | No plan | SEC |
| Nov 29, 2024 | Nov 29, 2024 | CADL | Officer, Director | Form 144 notice | 44,433 | $220k | Notice | SEC | |
| Jul 17, 2024 | Jul 19, 2024 | CADL | Chief Executive Officer | Form 4 sale | 22,528 | $146k | 6.4% | No plan | SEC |
| Jul 17, 2024 | Jul 17, 2024 | CADL | Officer, Director | Form 144 notice | 19,970 | $146k | Notice | SEC | |
| Jul 11, 2024 | Jul 15, 2024 | CADL | Chief Executive Officer | Form 4 sale | 20,293 | $121k | 5.4% | No plan | SEC |
| Jul 11, 2024 | Jul 11, 2024 | CADL | Officer, Director | Form 144 notice | 19,970 | $118k | Notice | SEC |